Rank 55 • MedTech & Devices
Pulmonx
Produces the Zephyr Valve, a minimally invasive implant to treat severe emphysema.
Visit website- Signal Score
- 86.7
- Total raised
- $170M
- Stage
- Public
- Founded
- 1995
- Headquarters
- Redwood City, USA
- Region
- North America
Their signal
Its highly validated, minimally invasive interventional pulmonology system boasts extensive peer-reviewed evidence and has successfully transformed therapeutic pathways for severe chronic obstructive pulmonary disease patients.
Signal Score 86.7editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.